ClinicalTrials.Veeva

Menu

Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU

TriHealth logo

TriHealth

Status

Completed

Conditions

PACU Length of Stay
Patient Satisfaction
Postoperative Vomiting
Postoperative Nausea

Treatments

Dietary Supplement: Coffee

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of the study is to determine if providing coffee to patients who self-identify as coffee drinkers postoperatively will decrease the length of stay in the post-anesthesia care unit (PACU).

Full description

Decreasing the length of stay in PACU for surgical patient is a pertinent outcome. The shorter length of stay can achieve higher patient engagement scores, while simultaneously increasing the productivity of the unit. This is achieved by making more beds available for new patients coming from the operating room (OR). One thought was that coffee would benefit the investigator's patients experience through a number of pathways. Initially, the stimulant effect of coffee would create a more alert patient. A more alert patient is more likely to comprehend home care instruction and be ready for discharge earlier. Coffee is often used as a remedy for morning sickness. Ideally the act of drinking coffee or even smelling the coffee may decrease the occurrence of Post-Operative Nausea and Vomiting (PONV) in investigator's patient population. Finally, patients frequently state that the inability to drink their morning coffee is often more difficult than not being able to eat prior to surgery. By allowing those to drink coffee in PACU this would make the patient feel that they are being cared for on an emotional level, in addition to a physical level.

Enrollment

178 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria:

  1. 18 years old or older
  2. Admitted to Bethesda North Minimally Invasive Surgery Center
  3. Reports to consume at least one cup of coffee a day for at least 5 days in a week

Exclusion Criteria

  1. History of PONV
  2. Pre-existing cardiac arrhythmias
  3. History of seizure disorder
  4. Pregnant

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

178 participants in 2 patient groups

Patients receiving coffee postoperatively
Experimental group
Description:
Patients who self-identify as coffee drinkers and receive coffee postoperatively
Treatment:
Dietary Supplement: Coffee
Patients not receiving coffee postoperatively
No Intervention group
Description:
Patients who self-identify as coffee drinkers and do not receive coffee postoperatively

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Rachel Baker, PhD, RN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems